The latest biotechnology news | Bio News
fda-approval-drug-research-development

FDA cuts back on Accelerated Approval pathway in 2022

The Accelerated Approval (AA) pathway, one of the U.S. Food and Drug Administration’s ...
Read More
cdc-LiNIONbajm4-unsplash-1

Common bacterial infections behind every eight death in the world in 2019, study says

One in eight global deaths in 2019 was caused by common bacterial infections, ...
Read More
capitol-gf8c464c53_1280

2022 midterms recap: what happened and what the results mean for biotech

The 2022 midterms are officially behind us – so, what happened, and what ...
Read More
vegetables-g5eb3905e4_1280

Spending bill should require FDA to clarify genome editing policy, lawmakers say

The 2023 appropriations legislation currently under debate in Congress should require the U.S. ...
Read More
15-melanoma

Moderna’s personalized mRNA melanoma vaccine achieves positive results

In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its ...
Read More
epa09573125 People walk past Pfizer?s headquarters in New York, New York, USA, 09 November 2021. Pfizer has asked regulators in the United States to approve COVID-19 vaccine booster shots for all adults 18 and older.  EPA-EFE/JUSTIN LANE

COVID-19 vaccines two years later: 3 million lives and a trillion dollars saved  

When nurse Sandra Lindsay received the first dose of the COVID-19 vaccine in ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

Health

BIO-CSBA report explains why and how states seek to attract biotech

While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract ...
Federal Policy

Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation

When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research and ...
BIO Events

BIO 2025 IP Conference: Challenging times for the laws that drive innovation

Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees (IPC) ...
Latest News

National Family Caregivers Month: Recognizing 63 million Americans

November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the crucial ...
BIO's View

Oncologist warns PBM step therapy has ‘crossed a dangerous line’

Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top